For immediate release
Contact: Mark Stejbach
Vice President & Chief Commercial Officer
Tengion, Inc.
mark.stejbach@tengion.com
We are happy to share with you a feature on the Discovery Science Channel's program "Future Of..." that highlighted Tengion and the promise of our regenerative medicine technology platform. The program focuses on the cutting-edge medical breakthroughs that are making advanced patient care and increased longevity a possibility. Tengion's CEO Dr. Steven Nichtberger is interviewed and discusses Tengion's integrated regenerative medicine approach and clinical development strategy. He also provides the show with a behind-the-scenes look at regenerative medicine research and development at Tengion's North Carolina lab facilities.
You can watch the video clip of this segment via the following link.
About Tengion
Tengion is a clinical-stage organ regeneration company with products in urologic, vascular and renal regeneration based on its proprietary Autologous Organ Regeneration Platform™. Tengion uses biocompatible materials and a patient's own (autologous) cells to create neo-organs or neo-tissues that are designed to catalyze the body's innate ability to regenerate. Tengion is a fully-integrated organization, with scalable U.S. and European manufacturing and distribution capabilities, experienced research, development, clinical and commercial teams, and significant intellectual property. Tengion's product candidates may ultimately address the most critical problems facing organ and tissue failure patients, enabling people to lead healthier lives without donor transplants or the side effects of related therapies.